New diagnostic index for prediction of severe irAEs in patients with metastatic melanoma taking checkpoint inhibitors.

被引：0
|
作者：
Zhukova, Natalia V.
Orlova, Rashida
Malkova, Anna
Kaledina, Ekaterina
Demchenkova, Alexandra
Naymushina, Polina
Nazarov, V.
Mazing, A.
Lapin, S.
Beliak, Natalia P.
Shoenfeld, Y.
机构：
[1] St Petersburg State Univ, Fac Med, St Petersburg, Russia
[2] St Petersburg State Univ, St Petersburg, Russia
[3] SPb SBIH, City Clin Oncol Dispensary, St Petersburg, Russia
[4] Pavlov First St Petersburg State Med Univ, St Petersburg, Russia
[5] Ariel Univ, Ariel, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21565
引用
收藏
页数：1
相关论文
共 50 条
  • [21] New Developments in the Treatment of Metastatic Melanoma: Immune Checkpoint Inhibitors and Targeted Therapies
    Azijli, Kaamar
    Stelloo, Ellen
    Peters, Godefridus J.
    Van den Eertwegh, Alfons J. M.
    ANTICANCER RESEARCH, 2014, 34 (04) : 1493 - 1505
  • [22] Outcomes of immune checkpoint inhibitors in patients with metastatic uveal melanoma treated with tebentafusp
    Koch, E. C.
    Ceballos, D. P. Arteaga
    Vilbert, M.
    Lajkosz, K.
    Muniz, T. Pimentel
    Hirsch, I.
    Ribeiro, M. F. Silva Almeida
    Mantle, L.
    Anczurowski, M.
    Hogg, D.
    Saibil, S.
    Spreafico, A.
    Krema, H.
    Butler, M. O.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S928 - S928
  • [23] The Effect of Immune-Checkpoint Inhibitors in Mortality among Patients with Metastatic Melanoma
    Raiker, Rahul
    Pakhchanian, Haig
    Wikholm, Colin
    Hochman, Edward
    Deng, Min
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB232 - AB232
  • [24] Association of Impaired Spermatogenesis With the Use of Immune Checkpoint Inhibitors in Patients With Metastatic Melanoma
    Scovell, Jason M.
    Benz, Karl
    Samarska, Iryna
    Kohn, Taylor P.
    Hooper, Jody E.
    Matoso, Andres
    Herati, Amin S.
    JAMA ONCOLOGY, 2020, 6 (08) : 1297 - 1299
  • [25] Hyponatremia and Nephritis - Rare Side Effects of Checkpoint Inhibitors in Patients with metastatic Melanoma
    Mitzel-Rink, H.
    Hassel, J.
    Berking, C.
    Gutzmer, R.
    Heinzerling, L.
    Majenka, P.
    Meier, F.
    Moreira, A.
    Terheyden, P.
    Thoms, K. M.
    Tietze, J.
    Zimmer, L.
    Kaehler, K.
    Loquai, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 15 - 15
  • [26] Immune checkpoint inhibitors retain effectiveness in older patients with cutaneous metastatic melanoma
    Howell, Ashley, V
    Gebregziabher, Mulugeta
    Thiers, Bruce H.
    Paulos, Chrystal M.
    Wrangle, John M.
    Hunt, Kelly J.
    Wallace, Kristin
    JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (03) : 394 - 401
  • [27] Toxicity, Response and Survival in Older Patients with Metastatic Melanoma Treated with Checkpoint Inhibitors
    de Glas, Nienke A.
    Bastiaannet, Esther
    van den Bos, Frederiek
    Mooijaart, Simon P.
    van der Veldt, Astrid A. M.
    Suijkerbuijk, Karlijn P. M.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Blank, Christian U.
    Boers-Sonderen, Marye J.
    van den Eertwegh, Alfonsus J. M.
    de Groot, Jan-Willem B.
    Haanen, John B. A. G.
    Hospers, Geke A. P.
    Jalving, Hilde
    Piersma, Djura
    van Rijn, Rozemarijn S.
    ten Tije, Albert J.
    Vreugdenhil, Gerard
    Wouters, Michel W. J. M.
    Portielje, Johanneke E. A.
    Kapiteijn, Ellen W.
    CANCERS, 2021, 13 (11)
  • [28] Impact of antibiotics on outcome in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
    Derosa, Lisa
    Routy, Bertrand
    Enot, David
    Baciarello, Giulia
    Massard, Christophe
    Loriot, Yohann
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [29] Plasma proteomics in patients with metastatic cutaneous melanoma treated with immune checkpoint inhibitors
    Eriksson, H.
    Babic, H.
    Lehtio, J.
    Pernemalm, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 536 - 536
  • [30] Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors
    Sander, Michael
    Stukalin, Igor
    Vallerand, Isabelle A.
    Goutam, Siddhartha
    Ewanchuk, Benjamin W.
    Meyers, Daniel E.
    Pabani, Aliyah
    Morris, Don
    Heng, Daniel Y. C.
    Cheng, Tina
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB170 - AB170
12345